Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 4, 2012, Pages 700-708

  Song, Tae Jun ^a   Kim, Ji Hoon ^b   Kim, Myung Hwan ^b   Jang, Ji Woong ^b   Park, Do Hyun ^b   Lee, Sang Soo ^b   Seo, Dong Wan ^b   Lee, Sung Koo ^b   Yu, Eunsil ^b  

^a Inje University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Autoimmune pancreatitis; Endoscopic retrograde cholangiopancreatography; Prevalence; Steroids

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KOREA; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PANCREAS RESECTION; PRIORITY JOURNAL; SEROLOGY; STEROID THERAPY; TREATMENT RESPONSE; TYPE 1 AUTOIMMUNE PANCREATITIS; TYPE 2 AUTOIMMUNE PANCREATITIS;

EID: 84863386287     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06934.x     Document Type: Article

References (23)

1. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009; 58: 1680-9.
2. Kloppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J. Gastroenterol. 2010; 45: 787-93.
3. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am. J. Gastroenterol. 2004; 99: 1605-16.
4. Song TJ, Kim MH, Moon SH etal. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am. J. Gastroenterol. 2010; 105: 1655-60.
5. Chari ST, Longnecker DS, Kloppel G. The diagnosis of autoimmune pancreatitis: a Western perspective. Pancreas 2009; 38: 846-8.
6. Maire F, Le Baleur Y, Rebours V etal. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am. J. Gastroenterol. 2011; 106: 151-6.
7. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am. J. Surg. Pathol. 2003; 27: 1119-27.
8. Zamboni G, Luttges J, Capelli P etal. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004; 445: 552-63.
9. Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am. J. Gastroenterol. 2009; 104: 2308-10.
10. Moon SH, Kim MH, Park DH etal. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57: 1704-12.
11. Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010; 139: 22-5.
12. Otsuki M, Chung JB, Okazaki K etal. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J. Gastroenterol. 2008; 43: 403-8.
13. Chari ST, Smyrk TC, Levy MJ etal. Diagnosis of autoimmune pancreatitis: the Mayo clinic experience. Clin. Gastroenterol. Hepatol. 2006; 4: 1010-16.
14. Chari ST, Takahashi N, Levy MJ etal. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin. Gastroenterol. Hepatol. 2009; 7: 1097-103.
15. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-6.
16. Frulloni L, Scattolini C, Falconi M etal. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am. J. Gastroenterol. 2009; 104: 2288-94.
17. Ryu JK, Chung JB, Park SW etal. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas 2008; 37: 377-85.
18. Sah RP, Chari ST, Pannala R etal. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010; 139: 140-8.
19. Weber SM, Cubukcu-Dimopulo O, Palesty JA etal. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J. Gastrointest. Surg. 2003; 7: 129-37.
20. Detlefsen S, Drewes AM. Autoimmune pancreatitis. Scand. J. Gastroenterol. 2009; 44: 1391-407.
21. Sugumar A, Levy MJ, Kamisawa T etal. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011; 65: 666-70.
22. Lerch MM, Mayerle J. The benefits of diagnostic ERCP in autoimmune pancreatitis. Gut 2011; 65: 565-6.
23. Shimosegawa T, Chari ST, Frulloni L etal. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-8.